VP of Revenue Operations
RoofrFull Time
Expert & Leadership (9+ years)
The Chief Clinical Officer (CCO) must possess extensive experience at the intersection of clinical practice, payer and employer quality programs, and AI product validation. This role requires a deep understanding of clinical standards and validation of AI findings, experience guiding radiologist partners, and the ability to ensure measurable value delivery across various stakeholders. Proven ability to represent clinical leadership externally and reinforce the company's position as a trusted partner is essential.
The CCO will ensure the integrity, consistency, and impact of Covera’s flagship initiatives by overseeing clinical standards and validation of AI findings. Responsibilities include guiding radiologist partners, ensuring Covera’s programs deliver measurable value, leading clinical validation of new AI tools, and maintaining clinical oversight of AI performance in production workflows. The CCO will also provide clinical governance for key programs, develop reporting frameworks for quality outcomes, and represent the clinical perspective in cross-functional collaborations to influence roadmap and program design.
Clinical intelligence platform for healthcare quality
Covera Health focuses on enhancing the quality of healthcare, particularly in the field of radiology, through its clinical intelligence platform. This platform uses scientifically validated tools to help doctors make more accurate diagnoses, which ultimately improves patient care. The company works with major employers, payers, and healthcare organizations, such as Walmart and Microsoft, to provide insights and tools powered by artificial intelligence. Covera Health's business model is based on partnerships with these organizations to implement programs that promote effective care and quality improvement on a large scale. Unlike many competitors, Covera Health specifically targets the needs of insured Americans and aims to raise healthcare standards across the country. The company received $25 million in Series C funding in August 2021 to support its mission.